311 related articles for article (PubMed ID: 32233455)
1. Sodium Copper Chlorophyllin Is Highly Effective against Enterovirus (EV) A71 Infection by Blocking Its Entry into the Host Cell.
Liu Z; Xia S; Wang X; Lan Q; Li P; Xu W; Wang Q; Lu L; Jiang S
ACS Infect Dis; 2020 May; 6(5):882-890. PubMed ID: 32233455
[TBL] [Abstract][Full Text] [Related]
2. Licochalcone A inhibits enterovirus A71 replication in vitro and in vivo.
Cao Y; Lei E; Wang X; Qi X; Li L; Ren J; Yang J; Wang S
Antiviral Res; 2021 Nov; 195():105091. PubMed ID: 34044060
[TBL] [Abstract][Full Text] [Related]
3. Development of single-step multiplex real-time RT-PCR assays for rapid diagnosis of enterovirus 71, coxsackievirus A6, and A16 in patients with hand, foot, and mouth disease.
Puenpa J; Suwannakarn K; Chansaenroj J; Vongpunsawad S; Poovorawan Y
J Virol Methods; 2017 Oct; 248():92-99. PubMed ID: 28662914
[TBL] [Abstract][Full Text] [Related]
4. Antiviral Peptides Targeting the Helicase Activity of Enterovirus Nonstructural Protein 2C.
Fang Y; Wang C; Wang C; Yang R; Bai P; Zhang XY; Kong J; Yin L; Qiu Y; Zhou X
J Virol; 2021 May; 95(12):. PubMed ID: 33789997
[TBL] [Abstract][Full Text] [Related]
5. In vitro antiviral activity of medicinal mushroom Ganoderma neo-japonicum Imazeki against enteroviruses that caused hand, foot and mouth disease.
Ang WX; Sarasvathy S; Kuppusamy UR; Sabaratnam V; Tan SH; Wong KT; Perera D; Ong KC
Trop Biomed; 2021 Sep; 38(3):239-247. PubMed ID: 34362866
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and managements of severe hand, foot and mouth disease caused by enterovirus A71 and coxsackievirus A16 in Shanghai, China.
Cai K; Wang Y; Guo Z; Yu H; Li H; Zhang L; Xu S; Zhang Q
BMC Infect Dis; 2019 Mar; 19(1):285. PubMed ID: 30917800
[TBL] [Abstract][Full Text] [Related]
7. Enterovirus A71 and coxsackievirus A16 show different replication kinetics in human neuronal and non-neuronal cell lines.
Yogarajah T; Ong KC; Perera D; Wong KT
Arch Virol; 2017 Mar; 162(3):727-737. PubMed ID: 27878462
[TBL] [Abstract][Full Text] [Related]
8. Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.
Takahashi S; Liao Q; Van Boeckel TP; Xing W; Sun J; Hsiao VY; Metcalf CJ; Chang Z; Liu F; Zhang J; Wu JT; Cowling BJ; Leung GM; Farrar JJ; van Doorn HR; Grenfell BT; Yu H
PLoS Med; 2016 Feb; 13(2):e1001958. PubMed ID: 26882540
[TBL] [Abstract][Full Text] [Related]
9. RSAD2 and AIM2 Modulate Coxsackievirus A16 and Enterovirus A71 Replication in Neuronal Cells in Different Ways That May Be Associated with Their 5' Nontranslated Regions.
Yogarajah T; Ong KC; Perera D; Wong KT
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263272
[TBL] [Abstract][Full Text] [Related]
10. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
Mao Q; Wang Y; Bian L; Xu M; Liang Z
Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal study on enterovirus A71 and coxsackievirus A16 genotype/subgenotype replacements in hand, foot and mouth disease patients in Thailand, 2000-2017.
Noisumdaeng P; Korkusol A; Prasertsopon J; Sangsiriwut K; Chokephaibulkit K; Mungaomklang A; Thitithanyanont A; Buathong R; Guntapong R; Puthavathana P
Int J Infect Dis; 2019 Mar; 80():84-91. PubMed ID: 30639624
[TBL] [Abstract][Full Text] [Related]
12. microRNA-4516 Contributes to Different Functions of Epithelial Permeability Barrier by Targeting Poliovirus Receptor Related Protein 1 in Enterovirus 71 and Coxsackievirus A16 Infections.
Hu Y; Song J; Liu L; Zhang Y; Wang L; Li Q
Front Cell Infect Microbiol; 2018; 8():110. PubMed ID: 29686973
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Recurrent Hand, Foot and Mouth Disease, China, 2008-2015.
Huang J; Liao Q; Ooi MH; Cowling BJ; Chang Z; Wu P; Liu F; Li Y; Luo L; Yu S; Yu H; Wei S
Emerg Infect Dis; 2018 Mar; 24(3):432-42. PubMed ID: 29460747
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of SP81 peptide against Enterovirus A71 (EV-A71).
Abd-Aziz N; Lee MF; Ong SK; Poh CL
Virology; 2024 Jan; 589():109941. PubMed ID: 37984152
[TBL] [Abstract][Full Text] [Related]
15. Type I Interferon-Induced TMEM106A Blocks Attachment of EV-A71 Virus by Interacting With the Membrane Protein SCARB2.
Guo X; Zeng S; Ji X; Meng X; Lei N; Yang H; Mu X
Front Immunol; 2022; 13():817835. PubMed ID: 35359978
[TBL] [Abstract][Full Text] [Related]
16. Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies.
Fang CY; Liu CC
Expert Opin Drug Discov; 2022 Jan; 17(1):27-39. PubMed ID: 34382876
[TBL] [Abstract][Full Text] [Related]
17. Spiramycin and azithromycin, safe for administration to children, exert antiviral activity against enterovirus A71 in vitro and in vivo.
Zeng S; Meng X; Huang Q; Lei N; Zeng L; Jiang X; Guo X
Int J Antimicrob Agents; 2019 Apr; 53(4):362-369. PubMed ID: 30599241
[TBL] [Abstract][Full Text] [Related]
18. Is a multivalent hand, foot, and mouth disease vaccine feasible?
Klein M; Chong P
Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of an experimental live combination vaccine against enterovirus 71 and coxsackievirus A16 in rhesus monkeys.
Yang T; Xie T; Song X; Shen D; Li H; Yue L; Jiang Q; Zhu F; Meng H; Long R; Yang R; Luo F; Xie Z
Hum Vaccin Immunother; 2020 Jul; 16(7):1586-1594. PubMed ID: 32159429
[TBL] [Abstract][Full Text] [Related]
20. [Hand-Foot-and-Mouth Disease, Aseptic Meningitis, and Encephalitis Caused by Enterovirus].
Fujimoto T
Brain Nerve; 2018 Feb; 70(2):121-131. PubMed ID: 29433113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
